ARCHIVES

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

More Shakeups Coming Cooperative groups; Chairmen Consider Mutimembership Problems

February 20, 1976

GAO Offers Two Suggestions For Plant Screening

April 4, 1980

CPRU Program Gets Basic Concept Approval

October 2, 1987

NCI Communications Director Sieber To Retire; Science Planner Waldrop Also To Leave NCI.

September 14, 2001

Sole Source Negotiations

March 7, 1975

Funding opportunities listed.

January 2, 2004